No significant differences were found in Gleason score (P = 0.209), preoperative prostate-specific antigen (PSA) levels (P = 0.561), hypertension (P = 0.663), and tumor staging (P = 0.172) between the two groups. The gene discussed is KLK3; the disease is neoplasm.